The successful use of streptomycin in the treatment of tuberculosis has been limited by the emergence of organisms resistant to the drug. Evidently in the resistant organism there is some change in the constitution of the cell that enables it to grow in an environment that prevents growth of the sensitive organism. An understanding of these changes in the cell itself is essential for a better understanding of how the drug accomplishes the inhibition of growth of the organi.sm.
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One method by which the mode of action of drugs can be studied is by a comparison of the growth and metabolism of a sensitive organism and its resistant variant. Since the production and function of cellular metabolites such as vitamins and amino acids are easily influenced by environmental factors, a comparison of the synthesizing abilities of the two strains would be of value in providing basic information concerning the effects of streptomycin on the vtamit and amino acid metabolism of the tubercle bacillus.
The purpose of this study was twofold: (1) to compare the synthesis of B-complex vitamins and certain amino acids by a normal human virulent strain of the tubercle bacillus and its streptomycin resistant variant, and (2) to study the effect of streptomycin on the vitamin synthesis by the resistant organism.
MATERIALS AND METHODS
The organisms employed in this study were the human strain, H37Rv, and its streptomycin-resistant variant, H37Rv-SR, of Mycobacterium tuberculosis obtained from William Steenken of the Trudeau Laboratory. The level of resistance of the resistant strain was > 1,000 j.gg per ml of streptomycin.
Test cultures of both strains were made by surface growth on 100 ml aliquots of the Proskauer-Beck synthetic medium in 16-ounce prescription bottles with asparagine serving as the source of nitrogen. In addition, the H37Rv-SR strain was cultured on this basic medium supplemented with streptomycin at levels of 1 Mg per ml, 10 Mg per ml, and 100 Mg per ml-Cultures were incubated in the dark in a horizontal position at 37 C for a six weeks' incubation period.
The cultures were harvested by filtration through no. 1 Whatman filter paper, passed through a Seitz filter, and the filtrates stored in the dark at 4 C until determinations were made. The organisms from each culture were autoclaved to kill, dried at 80 C, and weighed. Standard microbiological techniques were used for assaying the vitamins and amino acids. Vitamins and amino acids tested I Fellow of the National Tuberculosis Association. for included biotin, vitamin B12, folic acid, inositol, nicotinic acid, pantothenic acid, pyridoxine, riboflavin, thismin, arginine, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan, and valine. Determinations for each vitamin and amino acid were made on at least three different filtrates in order to eliminate possible variation by an individual culture.
Nitrogen determinations were done on each filtrate used for amino acid assay according to the micro-Kjeldahl method of Hiller, Plazin, and Van Slyke (1948) .
RESULTS
The cellular weight of the individual cultures was approximately equal for the two strains, but there was an over-all increase in the amount of total nitrogen in the filtrates of the streptomycin resistant organism. Nitrogen values on the normal strain covered a range of 0.379 to 0.424 mg nitrogen per milliliter of fil- The presence of streptomycin in the basal medium had little effect upon vitamin synthesis by the resistant organism. Production of inositol was increased to 17.33 ,g per ml and nicotinic acid to 42.1 ug per ml by the presence of 10 ,ug per ml of streptomycin. Increasing the concentration of streptomycin beyond this level failed to produce further increases in the production of these two vitamins. Table 2 shows the amount of ten amino acids synthesized by the two strains. The H37Rv-SR strain showed an increased production of arginine, isoleucine, leucine, lysine, and valine, and slightly decreased production of histidine and tryptophan. The range of variation observed among the different sample filtrates was fairly narrow, showing that under a given set of conditions amino acid elaboration is a constant function of the tubercle bacillus. Figure 1 shows the percentage of the total nitrogen occurring in the form of the various amino acids. These figures represent medium values. The most striking observation is the abundance of the hexone bases, arginine, lysine, and histidine. By conversion of the amino acid content of each filtrate to the percentage of total nitrogen, differences due to variations in the amount of nitrogen in the filtrate are eliminated. These results suggest that leucine, isoleucine, and valine are produced in greater quantities by the resistant strain, while histidine and tryptophan synthesis is greater in the streptomycin sensitive organism.
DISCUSSION
The results of this investigation indicate that certain variations do exist in the synthesizing powers of the H37Rv strain of the tubercle bacillus and its streptomycin resistant mutant, H37Rv-SR. More pronounced changes occur in the amino acid synthesis than in the synthesis of the B-complex vitamins.
The mechanisms by which the synthesizing abilities of resistant strains of an organism are altered are elemental to an explanation of the results obtained in this experiment. Since we have evidence that many drugs act by interference with enzyme systems, it is reasonable to assume that drug resistance can be acquired by alteration of the enzymatic constitution of the organism. Methods by which this change might be effected are by increased production of a metabolite or by development of a nonsensitive alternate pathway for the synthesis of the essential metabolite. Although an increased production of certain of the amino acids has been shown to be linked with streptomycin resistance in the tubercle bacillus, it is impossible to state whether such changes represent a true increase in synthesizing ability or are the result of an increased accumulation due to the loss of enzymes necessary for the utilization of the metabolite.
In a study of the synthesizing abilities of the human virulent H37Rv strain of Mycobacterium tuberculosis and its streptomycin resistant variant, H37Rv-SR, all of the B-complex vitamins and amino acids tested for were found to be synthesized by both strains in measurable amounts.
A slight decrease in the ability of the resistant strain to synthesize inositol was noted. Leucine, isoleucine, and valine were produced in greater amounts by the resistant strain, whereas synthesis of histidine and tryptophan was slightly decreased for this organism. These variations could not be accounted for on the basis of growth differences.
